Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

GoodRx is the number one healthcare platform for medication affordability and access, delivering proven solutions to integrate copay, patient services, and a unique cash pay option to help ...

Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small-molecule APIs to advance biocatalysis across pharma. Learn more about the ...

The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ahead after declining earnings in recent years. According to ZS consultant ...

The global market for pharmaceutical filtration is expected to grow from $12 billion in 2025 and is projected to reach $20.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.1 ...

From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026 ...

In today’s Pharma Pulse, Samsung Biologics enters the US market with a $280 million site acquisition, AstraZeneca secures a ...

In today’s Pharma Pulse, the FDA clears new denosumab biosimilars for osteoporosis and cancer-related bone loss, while ...

From therapeutic complexity, FDA regulatory policy changes, geopolitical shocks and an AI race, life sciences supply chain leaders are forced to rewrite their playbook to stay relevant in the era of ...

With the latest batch’s agreements, only three out of the 17 drugmakers initially targeted by Trump have not signed pricing ...